跳转至内容
Merck
CN

860692P

Avanti

C16:0 Ceramide (d18:2(4E,8Z)/16:0)

Avanti Research - A Croda Brand

别名:

N-palmitoyl-D-erythro-sphingosine (d18:2(4E,8Z) base)

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C34H65NO3
CAS Number:
分子量:
535.88
UNSPSC代码:
12352211
NACRES:
NA.25

Product Name

C16:0 Ceramide (d18:2(4E,8Z)/16:0), Avanti Research - A Croda Brand 860692P, powder

表单

powder

包装

pkg of 1 × 1 mg (860692P-1mg)

制造商/商品名称

Avanti Research - A Croda Brand 860692P

脂质类型

sphingolipids

运输

dry ice

储存温度

−20°C

SMILES字符串

OC[C@@](NC(CCCCCCCCCCCCCCC)=O)([H])[C@]([H])(O)/C=C/CC/C=C\CCCCCCCCC

InChI

1S/C34H65NO3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33(37)32(31-36)35-34(38)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h19,21,27,29,32-33,36-37H,3-18,20,22-26,28,30-31H2,1-2H3,(H,35,38)/b21-19-,29-27+/t32-,33+/m0/s1

InChI key

GMWIWVUTMCBDSP-JXXPSAROSA-N

一般描述

C16:0 Ceramide (d18:2(4E,8Z)/16:0) or N-palmitoyl-D-erythro-sphingosine (d18:2(4E,8Z) base) is a long chain ceramide derived from sphingosine containing two double bonds with palmitic acid. C16:0 Ceramide synthesis is catalyzed by the enzyme ceramide synthase 6 (CerS6).

生化/生理作用

C16:0-ceramide facilitates obesity-related insulin resistance. It exhibits pro-apoptotic function. Elevated levels of C16:0-ceramide has been observed in adipose tissue of obese patients.

包装

5 mL Amber Glass Screw Cap Vial (860692P-1mg)

法律信息

Avanti Research is a trademark of Avanti Polar Lipids, LLC

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

No data available

闪点(°C)

No data available


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持